1-2 of 2
Sonia Capellero
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CSPG4-Specific CAR.CIK Lymphocytes as a Novel Therapy for the Treatment of Multiple Soft-Tissue Sarcoma Histotypes

Valeria Leuci, Chiara Donini, Giovanni Grignani, Ramona Rotolo, Giulia Mesiano, Erika Fiorino, Loretta Gammaitoni, Lorenzo D'Ambrosio, Alessandra Merlini, Elisa Landoni, Enzo Medico, Sonia Capellero, Lidia Giraudo, Giulia Cattaneo, Ilenia Iaia, Ymera Pignochino, Marco Basiricò, Elisa Vigna, Alberto Pisacane, Franca Fagioli, Soldano Ferrone, Massimo Aglietta, Gianpietro Dotti, Dario Sangiolo
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (23): 6321–6334.
https://doi.org/10.1158/1078-0432.CCR-20-0357
Published: 01 December 2020
View article titled, CSPG4-Specific CAR.CIK Lymphocytes as a Novel Therapy for the Treatment of Multiple Soft-Tissue Sarcoma Histotypes
Open the PDF for CSPG4-Specific CAR.CIK Lymphocytes as a Novel Therapy for the Treatment of Multiple Soft-Tissue Sarcoma Histotypes in another window
Includes: Multimedia, Supplementary data
Journal Articles

Abstract GMM-023: PATIENT DERIVED XENOGRAFTS (PDXS) AND PDX DERIVED TUMOR CELLS (PDTC) ALLOW THE IDENTIFICATION OF ACTIONABLE CANCER GENES AND TREATMENT OPTIONS FOR PLATINUM REFRACTORY/RESISTANT OVARIAN CARCINOMAS

Martina Olivero, Jessica Erriquez, Maddalena Arigoni, Sonia Capellero, Concetta D'Ambrosio, Gloria Mittica, Fulvio Borella, Dionyssios Katsaros, Silvana Privitera, Enrico Berrino, Tiziana Venesio, Giorgio Valabrega, Raffaele Calogero, Maria Flavia Di Renzo
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (22_Supplement): GMM-023.
https://doi.org/10.1158/1557-3265.OVCASYMP18-GMM-023
Published: 15 November 2019
View article titled, Abstract GMM-023: PATIENT DERIVED XENOGRAFTS (PDXS) AND PDX DERIVED TUMOR CELLS (PDTC) ALLOW THE IDENTIFICATION OF ACTIONABLE CANCER GENES AND TREATMENT OPTIONS FOR PLATINUM REFRACTORY/RESISTANT OVARIAN CARCINOMAS